Surface immunofluorescence experiments using a human anti-i and two anti-I antisera have been performed on human peripheral blood lymphocytes. These are known to contain cold-reactive monoclonal IgM antibodies against the carbohydrate sequence:
patching and capping) can be elicited at 370C. Dual fluorescence experiments have shown striking concordant staining of I or i (fluorescein) caps and patches with concanavalin A (rhodamine) reactive sites on normal and leukemic cells, suggesting that a proportion of I and i active structures of lymphocyte membranes are structurally associated or physiologically coupled with glycoproteins carrying oligosaccharides with branched mannosyl cores. The I and i antigens are best known as surface antigens of human adult and fetal erythrocytes, respectively (1) . They are recognized by human autoantibodies, most of which are coldreactive monoclonal IgM proteins (2) . However, these antigens are not confined to human erythrocytes; they have been detected on human lymphocytes, polymorphonuclear leukocytes, macrophages (3) , and various cultured cells (4, 5) and in water-soluble form in certain secretions (2) . Moreover, they are variably expressed on erythrocytes (6) and cultured cell lines of several animal species (7, 8) .
The molecular basis of I and i specificities has been elucidated recently (9) (10) (11) : i activity has been shown to reside on the straight oligosaccharide chain Galf1 -4GlcNAcB1 -3Gal31 -4GlcNAcl1 -3Gal-The addition of a Galfl --4GlcNAcB1 -6 chain to the middle galactose converts it into a branched I-active structure on which various monoclonal anti-I antibodies recognize different oligosaccharide domains. Both of these structures serve as precursor chains for the blood group ABH antigens (12, 13) and for certain erythrocyte gangliosides (14) but their I and i activities are totally (in ABH antigens) or partially (in gangliosides) masked by these additional external substitutions.
The Ii antigens are not only of pathological interest as targets of autoantibodies in cold hemagglutinin disease (15) in man but they are also of considerable biological interest because of (i) the developmental changes-i to I in the first year of life-on human erythrocytes (1), (ii) the tumor-associated increase in expression of I in certain adenocarcinomas (16) , and (iii) the cell cycle-associated changes in i expression on lymphocytes (5) . Considerable information, is accumulating on the Ii active structures of erythrocyte membranes; these include band 3 protein (17), gangliosides (14) , and polyglycosyl ceramides (18) . Their antigenic change from i to I is believed to be associated with increased branching of carbohydrate chains (10) . The increased I antigen expression in adenocarcinomas of blood group ABH-secreting tissues is almost certainly associated with incomplete terminal glycosylations with accumulation of precursor chains (19) . Far less is known about the Ii active structures of lymphocytes.
In the present communication, dual-label surface fluorescence studies have shown that I-and i-active structures cocap with concanavalin A (Con A) receptors on peripheral blood lymphocytes. These observations suggest that a substantial proportion of the I and i activity is carried on or functionally associated with lymphocyte membrane proteins bearing oligosaccharides with the branched mannosyl cores (20) that are recognition sites for Con A.
MATERIALS AND METHODS Anti-I, Anti-i, and Control Sera. Two anti-I antisera (Ma and
Step) of different fine specificities and an anti-i serum (Den) were used in immunofluorescence experiments at dilutions of 1:100 (Ma) and 1:700 (Step and Den). These antisera were obtained from patients with chronic cold hemagglutinin disease and have been shown to contain monoclonal IgM K (Ma and Step) or IgM X (Den) antibodies (21, 22) . Anti GalB1 -4GlcNAc1l -3Galf31 -4GlcNAc1l -3Gal-. Ma recognizes the Galol1-4GlcNAc1 -6 chain (12) whose substitution onto the i-active sequence converts it into the Iactive structure (see refs. 10 and 11):
Step reacts best with the 1-4, 1-3 component of this branched I-active structure (10, 11) .
As a control, serum from a healthy donor (T.F.) was used to which 4 Immunofluorescence. Surface staining was performed as described (23) . Lymphocytes were incubated with RPMI-1640 medium, control serum, or anti-I or anti-i antiserum for 30 min at 4°C, washed twice at 4°C with medium, and incubated at 40C with fluorescein-conjugated F(ab')2 fragments of a goat antiserum specific for human 'y, ,u, K, and X chains (23 Dual-Label Fluorescence with Anti-i or Anti-I (Fluorescein) and Con A (Rhodamine). There was concordant staining of a high proportion of patches and caps formed with anti-I or anti-i and Con A. The coredistribution was noted with unfractionated peripheral blood lymphocytes from six donors as well as with the B-enriched, the chronic lymphocytic leukemia, and the acute prolymphocytic leukemia cells (Table 1 ). The concordant staining pattern was noted under all staining options: (i) I or i staining and capping followed by Con A staining at 4VC (summarized in Table 1 ); (ii) Con A staining and capping followed by I or i staining at 4VC (data not shown). The coincident staining was most pronounced under option i with which there was only a minor amount of Con A staining at sites negative for fluorescein (Ii) (Fig. 1) . Under option ii the concordance within individual cells was variable-i.e., the proportion of Con A patches showing concordant Ii staining varied and often there was some Ii staining at sites negative with Con A.
DISCUSSION
A high proportion of normal unfractionated and B-enriched peripheral blood lymphocytes and B-and T-cell type leukemia cells showed fluorescent staining with the anti-I and anti-i antisera. This is in agreement with previous lymphocytotoxicity (24) and antibody binding (25) Six healthy donors were tested with serum controls and anti-i Den; four donors were tested with anti-I
Step and Ma. I,i staining was first carried out at 40C; after warming to 370C for 10 min, Con A staining was performed at 4VC. § The majority of F + R positive cells showed concordant capping with all four donors; however, formal counting of concordant cells was performed with one donor only. One donor. 1 1 Less than 100 cells counted.
anti-I Ma of the chronic lymphocytic leukemia cells (relative to normal lymphocytes) is also in agreement with previous data (3, 24) .
The human monoclonal anti-I and anti-i antibodies are powerful reagents recognizing defined carbohydrate chains on cell surfaces. However, their rapid dissociation from their antigens at 370C imposes limitations on their use in biological experiments. However, the present studies have shown that, in the presence of a second antibody (anti-human Ig), the I-anti-I and i-anti-i complexes at the cell surface become stabilized. Thus, redistribution (capping) experiments at 370C can be performed. The Ii fluorescence was very bright, and the capping and patching of these antigens occurred more rapidly than the capping of surface Ig of B lymphocytes; therefore, Ii caps could be easily distinguished from the Ig fluorescence after 10 min of warming.
Concordant redistribution of Con A receptors with I and i antigens was observed with normal and leukemic peripheral blood lymphocytes, especially when the Ii antigens were redistributed first. This suggests that a high proportion of Con A-reactive structures are closely associated with Ii-active structures on lymphocyte membranes, and the possibility is raised that a substantial proportion of Ii structurest are carried on glycoproteins bearing branched mannosyl cores which are reactive with Con A (20) . The I and i antigens have previously been shown to occur on glycoproteins (mucins) with O-glycosidically linked carbohydrate chains (12) and on glycosphingolipids and gangliosides of erythrocyte membranes (9, 10, 14) which are usually devoid of oligosaccharide chains with mannosyl core structures. The first indication that they may also be carried on glycoproteins with oligomannosyl structures came from affinity chromatography experiments in which purified anti-I and anti-i antibodies were used as adsorbents to isolate the I-and i-active components from pepsin-digested human amniotic fluid (2) . Small amounts of mannose were regularly found in the eluted antigen preparations.
In addition, structural studies of glycopeptides of bovine thymus plasma membranes (26) (17) . Moreover, polyglycosyl peptides have recently been isolated from Pronase-digested erythrocyte membranes (27) (8) .
Among the numerous lymphocyte glycoproteins that bind (29) , and the demonstration of associated redistribution of cycli GMP and its related kinase which are considered to be invblved with lymphocyte activation (30) suggest important biological roles for the I,i oligosaccharides as surface structures whose perturbations are communicated to the interior of cells.
